Comments on: AstraZeneca sells US rights to Sobi https://ukinvestormagazine.co.uk/astrazeneca-sells-us-rights-to-sobi/ UK Investor Magazine provides breaking financial news and investment ideas Thu, 14 Feb 2019 09:37:13 +0000 hourly 1 https://wordpress.org/?v=6.8.5 By: AstraZeneca meets guidance as new medicines lead strong performance - UK Investor Magazine https://ukinvestormagazine.co.uk/astrazeneca-sells-us-rights-to-sobi/#comment-9554 Thu, 14 Feb 2019 09:37:13 +0000 https://ukinvestormagazine.co.uk/?p=16202#comment-9554 […] treatment for a rare disease was granted orphan status. During the 2018 financial year, it sold its US rights to its respiratory tract infection treatment to the Swedish company Sobi. Additionally, it sold its […]

]]> By: ReNeuron shares rally despite first-half loss - UK Investor Magazine https://ukinvestormagazine.co.uk/astrazeneca-sells-us-rights-to-sobi/#comment-9051 Fri, 14 Dec 2018 10:21:38 +0000 https://ukinvestormagazine.co.uk/?p=16202#comment-9051 […] cancer medicine failed to meet its primary objective in November. Equally, the company sold its US rights to Sobi and […]

]]> By: AstraZeneca cancer medicine fails to meet main objective - UK Investor Magazine https://ukinvestormagazine.co.uk/astrazeneca-sells-us-rights-to-sobi/#comment-8847 Fri, 16 Nov 2018 12:44:57 +0000 https://ukinvestormagazine.co.uk/?p=16202#comment-8847 […] this week, AstraZeneca announced that it will sell its US rights to its respiratory tract infection treatment to a Swedish company. Moreover, it also sold the rights to its acid-reflux medicine Grunenthal at […]

]]>